Tainan, Taiwan

Tai-Yan Liao

This inventor holds 2 USPTO granted patents. Top assignee: Academia Sinica. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tai-Yan Liao. Retrieved from https://idiyas.com/inventor/tai-yan-liao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Tai-Yan Liao in Protein Aggregate Treatment

Introduction

Tai-Yan Liao is a prominent inventor based in Tainan, Taiwan. He has made significant contributions to the field of biomedical research, particularly in the treatment of diseases associated with abnormal protein aggregates. His innovative work has the potential to impact the lives of many individuals suffering from neurodegenerative diseases.

Latest Patents

Tai-Yan Liao holds a patent for "Bipartite molecules and uses thereof in treating diseases associated with abnormal protein aggregates." This patent describes bipartite molecules that comprise a peptide affinity moiety and at least one charged moiety. These molecules are designed to reduce the formation of abnormal protein aggregates and treat diseases characterized by such aggregates, including neurodegenerative diseases.

Career Highlights

Liao is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to focus on groundbreaking research that addresses critical health issues related to protein aggregation.

Collaborations

Tai-Yan Liao collaborates with esteemed colleagues, including Benjamin Pang-Hsien Tu and Rita Py Chen. Their combined expertise enhances the research efforts aimed at developing effective treatments for diseases linked to protein aggregates.

Conclusion

Tai-Yan Liao's innovative contributions to the field of biomedical research highlight the importance of addressing protein aggregation in disease treatment. His work continues to pave the way for advancements in medical science and offers hope for those affected by neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…